Candel Therapeutics (CADL)

• Market cap: $246M
• 1 day: -6.08%
• 5 days: -2.82%
• 1 month: -14.18%
• 3 months: -23.55%
• 6 months: -19.86%
• Year to date: -50.17%
• 1 year: -1.97%
• 5 years: -36%
• 10 years: -36%
• Sector: Healthcare
• Industry: Biotechnology

About: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Employees: 38